(Q30757070)

26 June 2017

Subglottic haemangioma: controversies in management (English)

1 reference

26 June 2017

Walker P

1

1 reference

PubMed ID

10457300

26 June 2017

Cooper D

series ordinal

2

1 reference

PubMed ID

10457300

26 June 2017

MacDonald D

series ordinal

3

1 reference

26 June 2017

1 August 1999

1 reference

Journal of Paediatrics and Child Health

26 June 2017

1 reference

26 June 2017

35

1 reference

26 June 2017

392-395

1 reference

26 June 2017

4

1 reference

Infantile subglottic hemangiomas. An update

26 June 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Cellular markers that distinguish the phases of hemangioma during infancy and childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

21 January 2018

Subglottic haemangioma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Contrasting strategic approaches to the management of subglottic hemangiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Subglottic hemangioma: ten years' experience with the carbon dioxide laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Open surgical excision of subglottic hemangioma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Infantile subglottic hemangioma: a review and presentation of two cases of surgical excision

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Hepatic vascular anomalies in infancy: a twenty-seven-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

The use of interferon alfa-2a for life-threatening hemangiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Treatment of massive or life-threatening hemangiomas with recombinant alpha(2a)-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Interferon alfa-2a therapy for airway hemangiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

Interferon therapy in paediatric practice: new applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.1999.00380.X

10.1046/J.1440-1754.1999.00380.X

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference